Melanie L. Ufkin, Ph.D. - Publications
Affiliations: | 2013 | The University of Maine, Orono, ME, United States |
Area:
Molecular Biology, Cell BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Peterson SM, Thompson JA, Ufkin ML, Sathyanarayana P, Liaw L, Congdon CB. Common features of microRNA target prediction tools. Frontiers in Genetics. 5: 23. PMID 24600468 DOI: 10.3389/Fgene.2014.00023 | 0.515 | |||
2014 | Ufkin ML, Peterson S, Yang X, Driscoll H, Duarte C, Sathyanarayana P. miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia. Leukemia Research. 38: 402-10. PMID 24484870 DOI: 10.1016/J.Leukres.2013.12.021 | 0.582 | |||
2012 | Sathyanarayana P, Dev A, Pradeep A, Ufkin M, Licht JD, Wojchowski DM. Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2. Blood. 119: 5522-31. PMID 22508938 DOI: 10.1182/Blood-2011-11-392571 | 0.521 | |||
2012 | Ufkin M, Sathyanarayana P. Ectopic Expression of Mir-125a or Mubritinib Treatment of Human Acute Promyelocytic Leukemia t(15; 17) NB4 Cells Containing Epigenitically Silenced Mir-125a Results in Inhibition of Cell Cycle Progression Through Targeting the Erbb2 Pathway. Blood. 120: 2426-2426. DOI: 10.1182/Blood.V120.21.2426.2426 | 0.59 | |||
Show low-probability matches. |